{"id":10849,"date":"2023-10-17T13:18:25","date_gmt":"2023-10-17T16:18:25","guid":{"rendered":"https:\/\/ocanal.com\/noticias\/corporativas\/neu-refix-%ce%b2-glucano-reduz-a-fibrose-muscular-em-camundongos-mdx-com-distrofia-muscular-de-duchenne-em-pesquisa-conjunta-com-o-dr-yoshitsugu-aoki-do-ncnp-de-toquio-japao\/"},"modified":"2023-10-17T13:18:25","modified_gmt":"2023-10-17T16:18:25","slug":"neu-refix-%ce%b2-glucano-reduz-a-fibrose-muscular-em-camundongos-mdx-com-distrofia-muscular-de-duchenne-em-pesquisa-conjunta-com-o-dr-yoshitsugu-aoki-do-ncnp-de-toquio-japao","status":"publish","type":"post","link":"https:\/\/ocanal.com\/noticias\/corporativas\/neu-refix-%ce%b2-glucano-reduz-a-fibrose-muscular-em-camundongos-mdx-com-distrofia-muscular-de-duchenne-em-pesquisa-conjunta-com-o-dr-yoshitsugu-aoki-do-ncnp-de-toquio-japao\/","title":{"rendered":"Neu REFIX \u03b2-glucano reduz a fibrose muscular em camundongos mdx com distrofia muscular de Duchenne em pesquisa conjunta com o dr. Yoshitsugu Aoki do NCNP de T\u00f3quio (Jap\u00e3o)"},"content":{"rendered":"<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\nA fibrose no m\u00fasculo esquel\u00e9tico que leva&agrave;disfun\u00e7\u00e3o locomotora na distrofia muscular de Duchenne (DMD) pode ser significativamente reduzida em camundongos mdx com DMD mediante a administra\u00e7\u00e3o por via oral do Neu REFIX beta 1,3-1,6 glucanos em solit\u00e1rio (sem quaisquer outros medicamentos) durante 45 dias. Essa pesquisa foi realizada em conjunto com a equipe do <a href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.ncnp.go.jp%2Fnin%2Fguide%2Fr_dna2%2Fgreeting_en.html&amp;esheet=53620489&amp;newsitemid=20231016225712&amp;lan=pt-BR&amp;anchor=dr.+Yoshitsugu+Aoki&amp;index=1&amp;md5=1e089be26df3ceaa7679099c8782b170\" rel=\"nofollow noopener\" shape=\"rect\" target=\"_blank\">dr. Yoshitsugu Aoki<\/a>, chefe do Departamento de Terapia Molecular do Centro Nacional de Neurologia e Psiquiatria (NCNP), em T\u00f3quio (Jap\u00e3o), <a href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.ncnp.go.jp%2Ftopics%2F2022%2F20220317e.html&amp;esheet=53620489&amp;newsitemid=20231016225712&amp;lan=pt-BR&amp;anchor=pioneiro+no+desenvolvimento+de+solu%26ccedil%3B%26otilde%3Bes+para+DMD%2C+como+a+terapia+de+salto+de+exon&amp;index=2&amp;md5=e038a7843ecb858c75cbcf29f8d23ce9\" rel=\"nofollow noopener\" shape=\"rect\" target=\"_blank\">pioneiro no desenvolvimento de solu\u00e7\u00f5es para DMD, como a terapia de salto de exon<\/a>. As conclus\u00f5es publicadas na <a href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.nature.com%2Farticles%2Fs41598-023-44330-0&amp;esheet=53620489&amp;newsitemid=20231016225712&amp;lan=pt-BR&amp;anchor=Scientific+Reports%2C&amp;index=3&amp;md5=ed818d72bd31ec60e16952d7b2162c62\" rel=\"nofollow noopener\" shape=\"rect\" target=\"_blank\"><i>Scientific Reports<\/i>,<\/a> uma publica\u00e7\u00e3o do portf\u00f3lio da Nature, tamb\u00e9m relataram uma redu\u00e7\u00e3o na inflama\u00e7\u00e3o muscular, que precede a fibrose e a disfun\u00e7\u00e3o muscular, levando gradualmente&agrave;insufici\u00eancia muscular respirat\u00f3ria seguida de disfun\u00e7\u00e3o pulmonar, fibrose card\u00edaca, insufici\u00eancia card\u00edaca e morte prematura.<\/p>\n<p id=\"news-body-cta\" xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">Este comunicado de imprensa inclui multim\u00e9dia. Veja o comunicado completo aqui: <a href=\"https:\/\/www.businesswire.com\/news\/home\/20231016225712\/pt\/\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/www.businesswire.com\/news\/home\/20231016225712\/pt\/<\/a><\/p>\n<div id=\"bwbodyimg\" style=\"width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;\" xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20231016225712\/pt\/1917231\/4\/GNC_PR_65_MDX_Sci_Rep_BW_Ill_1.4_OL_17Oct23.jpg\" alt=\"An illustrative summary of the research outcome with Neu REFIX Beta glucan presents, several \u201cFirsts\u201d to its credit; (1) Oral consumption of a food supplement alone, without any other drugs, reducing skeletal muscle fibrosis in MDX mice, (2) In clinical studies, increase in plasma dystrophin which is considered of relevance to correction of vascular smooth muscle pathology, (3) Clinically evident beneficial reconstitution of gut microbiome in patients with DMD in a 45- days clinical study, (4) Reduction of myocardial fibrosis with neu REFIX alone in MDX mice, (5) Slowing down the progress of DMD pathology evident by 6MWT, NSAA and MRC in a six-month clinical study when Neu REFIX was consumed along with standard of care medication; Neu REFIX 1,3-1,6 Beta glucan is a food supplement without any therapeutic claims; Not a drug or remedy to any illness. Research findings not to be construed as medical advice. Neu REFIX doesn\u2019t contain any of the commonly notified 28 allergens.\"><\/p>\n<p style=\"font-size:85%;\">An illustrative summary of the research outcome with Neu REFIX Beta glucan presents, several \u201cFirsts\u201d to its credit; (1) Oral consumption of a food supplement alone, without any other drugs, reducing skeletal muscle fibrosis in MDX mice, (2) In clinical studies, increase in plasma dystrophin which is considered of relevance to correction of vascular smooth muscle pathology, (3) Clinically evident beneficial reconstitution of gut microbiome in patients with DMD in a 45- days clinical study, (4) Reduction of myocardial fibrosis with neu REFIX alone in MDX mice, (5) Slowing down the progress of DMD pathology evident by 6MWT, NSAA and MRC in a six-month clinical study when Neu REFIX was consumed along with standard of care medication; Neu REFIX 1,3-1,6 Beta glucan is a food supplement without any therapeutic claims; Not a drug or remedy to any illness. Research findings not to be construed as medical advice. Neu REFIX doesn\u2019t contain any of the commonly notified 28 allergens.<\/p>\n<\/div>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\nEste estudo \u00e9 a sequ\u00eancia de um ensaio cl\u00ednico pr\u00e9vio com 27 pacientes divididos em dois grupos, que confirmou a seguran\u00e7a, assim como a <a href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.sciencedirect.com%2Fscience%2Farticle%2Fpii%2FS2667242123000556&amp;esheet=53620489&amp;newsitemid=20231016225712&amp;lan=pt-BR&amp;anchor=redu%26ccedil%3B%26atilde%3Bo+da+inflama%26ccedil%3B%26atilde%3Bo+e+fibrose+e+o+aumento+da+distrofia+plasm%26aacute%3Btica&amp;index=4&amp;md5=9c5c7eb03ec0e806c94166a983e57575\" rel=\"nofollow noopener\" shape=\"rect\" target=\"_blank\">redu\u00e7\u00e3o da inflama\u00e7\u00e3o e fibrose e o aumento da distrofia plasm\u00e1tica<\/a>, naqueles que consumiram os Neu REFIX \u03b2-glucanos junto com os medicamentos padr\u00e3o, em compara\u00e7\u00e3o com o grupo de controle que tomou apenas os medicamentos padr\u00e3o. Um avan\u00e7o importante neste estudo com animais \u00e9 que os camundongos mdx do grupo de tratamento consumiram apenas os Neu REFIX \u03b2-glucanos, sem outros medicamentos, ao contr\u00e1rio do estudo cl\u00ednico. Atualmente, n\u00e3o existem rem\u00e9dios definitivos e eficazes dispon\u00edveis para a DMD. A terapia de salto de exon est\u00e1 dispon\u00edvel somente para menos de 30% dos pacientes com dele\u00e7\u00f5es espec\u00edficas de exon e a terapia gen\u00e9tica pode n\u00e3o ser aplic\u00e1vel a pacientes em est\u00e1gios avan\u00e7ados de DMD. Com base na nossa experi\u00eancia cl\u00ednica, vale a pena validar clinicamente os Neu REFIX \u03b2-glucanos por uma dura\u00e7\u00e3o mais longa, tanto como uma op\u00e7\u00e3o independente quanto como um adjuvante dos medicamentos padr\u00e3o de tratamento, em diferentes conjuntos de faixas et\u00e1rias apropriadas de pacientes \u2013 opina o dr. Raghavan, que concluiu recentemente outro <a href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.mdaconference.org%2Fabstract-library%2Fefficacy-of-a-safe-s-glucan-in-improving-muscle-function-in-duchenne-muscular-dystrophy-results-of-a-6-month-nonrandomized-open-label-extension-trial%2F&amp;esheet=53620489&amp;newsitemid=20231016225712&amp;lan=pt-BR&amp;anchor=estudo+cl%26iacute%3Bnico+com+dura%26ccedil%3B%26atilde%3Bo+de+seis+meses+em+que+o+Neu+REFIX+produziu+melhora+no+TC6%2C+NSAA+e+MRC&amp;index=5&amp;md5=6e5a5694522d614ca543428b4ea88629\" rel=\"nofollow noopener\" shape=\"rect\" target=\"_blank\">estudo cl\u00ednico com dura\u00e7\u00e3o de seis meses em que o Neu REFIX produziu melhora no TC6, NSAA e MRC<\/a>.<\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\nCom <a href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.mdaconference.org%2Fabstract-library%2Fenhanced-muscle-regeneration-in-mdx-duchenne-muscular-dystrophy-mice-proven-by-cd44-myh3-on-consumption-of-a-pullulans-produced-neu-refix-s-glucan%2F&amp;esheet=53620489&amp;newsitemid=20231016225712&amp;lan=pt-BR&amp;anchor=experimentos+adicionais+em+camundongos+mdx+em+andamento&amp;index=6&amp;md5=187bd6e976056cf50ffce861f5d6af8b\" rel=\"nofollow noopener\" shape=\"rect\" target=\"_blank\">experimentos adicionais em camundongos mdx em andamento<\/a>,&agrave;medida que mais dados s\u00e3o disponibilizados, pode ser um valor agregado recomendar o Neu REFIX \u03b2-glucano para pacientes com DMD, segundo o dr. Yoshitsugu Aoki. A <a href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fdoi.org%2F10.1101%2F2023.09.25.559276&amp;esheet=53620489&amp;newsitemid=20231016225712&amp;lan=pt-BR&amp;anchor=redu%26ccedil%3B%26atilde%3Bo+da+fibrose+mioc%26aacute%3Brdica+em+camundongos+mdx&amp;index=7&amp;md5=82237ff52d72d15a942d8d39b65821ad\" rel=\"nofollow noopener\" shape=\"rect\" target=\"_blank\">redu\u00e7\u00e3o da fibrose mioc\u00e1rdica em camundongos mdx<\/a> e a <a href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fdoi.org%2F10.1101%2F2022.12.09.22283273&amp;esheet=53620489&amp;newsitemid=20231016225712&amp;lan=pt-BR&amp;anchor=reconstitui%26ccedil%3B%26atilde%3Bo+ben%26eacute%3Bfica+do+microbioma+intestinal+em+estudos+cl%26iacute%3Bnicos&amp;index=8&amp;md5=a8285b83bbdf2ca4bb7163e65eeda22e\" rel=\"nofollow noopener\" shape=\"rect\" target=\"_blank\">reconstitui\u00e7\u00e3o ben\u00e9fica do microbioma intestinal em estudos cl\u00ednicos<\/a> nos d\u00e3o a esperan\u00e7a de que este suplemento alimentar seguro e de consumo oral, livre de al\u00e9rgenos, possa se tornar um adjuvante valioso para tratamentos modificadores de doen\u00e7as na DMD \u2013 defende a equipe de pesquisa que apresentou os dados no World Muscle Society 2023 e no World Congress of Neurology 2023.<\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\nO texto no idioma original deste an\u00fancio \u00e9 a vers\u00e3o oficial autorizada. As tradu\u00e7\u00f5es s\u00e3o fornecidas apenas como uma facilidade e devem se referir ao texto no idioma original, que \u00e9 a \u00fanica vers\u00e3o do texto que tem efeito legal.<\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\"><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20231016225712r1&amp;sid=brdno&amp;distro=ftp\"><span class=\"bwct31415\"><\/span><\/p>\n<p id=\"mmgallerylink\" xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\"><span id=\"mmgallerylink-phrase\">Ver a vers\u00e3o original em businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20231016225712\/pt\/\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/www.businesswire.com\/news\/home\/20231016225712\/pt\/<\/a><\/span><\/p>\n<p><b>Contato:<\/b><\/p>\n<p>\nSamuel JK Abraham\n<\/p>\n<p><a href=\"mailto:info@gncorporation.com\" rel=\"nofollow\" shape=\"rect\">info@gncorporation.com<\/a><\/p>\n<p><strong>Fonte: <\/strong><a href='http:\/\/www.businesswire.com\/portal\/site\/home\/' target='_blank' rel=\"noopener\">BUSINESS WIRE<\/a><img src='https:\/\/api.dino.com.br\/v2\/news\/tr\/294586?partnerId=3197' alt=\"\" style=\"border:0px;width:1px;height:1px;\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>A fibrose no m\u00fasculo esquel\u00e9tico que leva&agrave;disfun\u00e7\u00e3o locomotora na distrofia muscular de Duchenne (DMD) pode ser significativamente reduzida em camundongos mdx com DMD mediante a administra\u00e7\u00e3o por via oral do Neu REFIX beta 1,3-1,6 glucanos em solit\u00e1rio (sem quaisquer outros medicamentos) durante 45 dias. Essa pesquisa foi realizada em conjunto com a equipe do dr. [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[],"class_list":["post-10849","post","type-post","status-publish","format-standard","hentry","category-noticias"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Neu REFIX \u03b2-glucano reduz a fibrose muscular em camundongos mdx com distrofia muscular de Duchenne em pesquisa conjunta com o dr. Yoshitsugu Aoki do NCNP de T\u00f3quio (Jap\u00e3o) - Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ocanal.com\/noticias\/corporativas\/neu-refix-\u03b2-glucano-reduz-a-fibrose-muscular-em-camundongos-mdx-com-distrofia-muscular-de-duchenne-em-pesquisa-conjunta-com-o-dr-yoshitsugu-aoki-do-ncnp-de-toquio-japao\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Neu REFIX \u03b2-glucano reduz a fibrose muscular em camundongos mdx com distrofia muscular de Duchenne em pesquisa conjunta com o dr. Yoshitsugu Aoki do NCNP de T\u00f3quio (Jap\u00e3o) - Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios\" \/>\n<meta property=\"og:description\" content=\"A fibrose no m\u00fasculo esquel\u00e9tico que leva&agrave;disfun\u00e7\u00e3o locomotora na distrofia muscular de Duchenne (DMD) pode ser significativamente reduzida em camundongos mdx com DMD mediante a administra\u00e7\u00e3o por via oral do Neu REFIX beta 1,3-1,6 glucanos em solit\u00e1rio (sem quaisquer outros medicamentos) durante 45 dias. Essa pesquisa foi realizada em conjunto com a equipe do dr. [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ocanal.com\/noticias\/corporativas\/neu-refix-\u03b2-glucano-reduz-a-fibrose-muscular-em-camundongos-mdx-com-distrofia-muscular-de-duchenne-em-pesquisa-conjunta-com-o-dr-yoshitsugu-aoki-do-ncnp-de-toquio-japao\/\" \/>\n<meta property=\"og:site_name\" content=\"Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios\" \/>\n<meta property=\"article:published_time\" content=\"2023-10-17T16:18:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20231016225712\/pt\/1917231\/4\/GNC_PR_65_MDX_Sci_Rep_BW_Ill_1.4_OL_17Oct23.jpg\" \/>\n<meta name=\"author\" content=\"DINO\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"DINO\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/neu-refix-%ce%b2-glucano-reduz-a-fibrose-muscular-em-camundongos-mdx-com-distrofia-muscular-de-duchenne-em-pesquisa-conjunta-com-o-dr-yoshitsugu-aoki-do-ncnp-de-toquio-japao\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/neu-refix-%ce%b2-glucano-reduz-a-fibrose-muscular-em-camundongos-mdx-com-distrofia-muscular-de-duchenne-em-pesquisa-conjunta-com-o-dr-yoshitsugu-aoki-do-ncnp-de-toquio-japao\\\/\"},\"author\":{\"name\":\"DINO\",\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/#\\\/schema\\\/person\\\/24f7b50e924d81f1023b69582993c0ff\"},\"headline\":\"Neu REFIX \u03b2-glucano reduz a fibrose muscular em camundongos mdx com distrofia muscular de Duchenne em pesquisa conjunta com o dr. Yoshitsugu Aoki do NCNP de T\u00f3quio (Jap\u00e3o)\",\"datePublished\":\"2023-10-17T16:18:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/neu-refix-%ce%b2-glucano-reduz-a-fibrose-muscular-em-camundongos-mdx-com-distrofia-muscular-de-duchenne-em-pesquisa-conjunta-com-o-dr-yoshitsugu-aoki-do-ncnp-de-toquio-japao\\\/\"},\"wordCount\":769,\"image\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/neu-refix-%ce%b2-glucano-reduz-a-fibrose-muscular-em-camundongos-mdx-com-distrofia-muscular-de-duchenne-em-pesquisa-conjunta-com-o-dr-yoshitsugu-aoki-do-ncnp-de-toquio-japao\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20231016225712\\\/pt\\\/1917231\\\/4\\\/GNC_PR_65_MDX_Sci_Rep_BW_Ill_1.4_OL_17Oct23.jpg\",\"articleSection\":[\"Not\u00edcias Corporativas\"],\"inLanguage\":\"pt-BR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/neu-refix-%ce%b2-glucano-reduz-a-fibrose-muscular-em-camundongos-mdx-com-distrofia-muscular-de-duchenne-em-pesquisa-conjunta-com-o-dr-yoshitsugu-aoki-do-ncnp-de-toquio-japao\\\/\",\"url\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/neu-refix-%ce%b2-glucano-reduz-a-fibrose-muscular-em-camundongos-mdx-com-distrofia-muscular-de-duchenne-em-pesquisa-conjunta-com-o-dr-yoshitsugu-aoki-do-ncnp-de-toquio-japao\\\/\",\"name\":\"Neu REFIX \u03b2-glucano reduz a fibrose muscular em camundongos mdx com distrofia muscular de Duchenne em pesquisa conjunta com o dr. Yoshitsugu Aoki do NCNP de T\u00f3quio (Jap\u00e3o) - Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/neu-refix-%ce%b2-glucano-reduz-a-fibrose-muscular-em-camundongos-mdx-com-distrofia-muscular-de-duchenne-em-pesquisa-conjunta-com-o-dr-yoshitsugu-aoki-do-ncnp-de-toquio-japao\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/neu-refix-%ce%b2-glucano-reduz-a-fibrose-muscular-em-camundongos-mdx-com-distrofia-muscular-de-duchenne-em-pesquisa-conjunta-com-o-dr-yoshitsugu-aoki-do-ncnp-de-toquio-japao\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20231016225712\\\/pt\\\/1917231\\\/4\\\/GNC_PR_65_MDX_Sci_Rep_BW_Ill_1.4_OL_17Oct23.jpg\",\"datePublished\":\"2023-10-17T16:18:25+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/#\\\/schema\\\/person\\\/24f7b50e924d81f1023b69582993c0ff\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/neu-refix-%ce%b2-glucano-reduz-a-fibrose-muscular-em-camundongos-mdx-com-distrofia-muscular-de-duchenne-em-pesquisa-conjunta-com-o-dr-yoshitsugu-aoki-do-ncnp-de-toquio-japao\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/neu-refix-%ce%b2-glucano-reduz-a-fibrose-muscular-em-camundongos-mdx-com-distrofia-muscular-de-duchenne-em-pesquisa-conjunta-com-o-dr-yoshitsugu-aoki-do-ncnp-de-toquio-japao\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/neu-refix-%ce%b2-glucano-reduz-a-fibrose-muscular-em-camundongos-mdx-com-distrofia-muscular-de-duchenne-em-pesquisa-conjunta-com-o-dr-yoshitsugu-aoki-do-ncnp-de-toquio-japao\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20231016225712\\\/pt\\\/1917231\\\/4\\\/GNC_PR_65_MDX_Sci_Rep_BW_Ill_1.4_OL_17Oct23.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20231016225712\\\/pt\\\/1917231\\\/4\\\/GNC_PR_65_MDX_Sci_Rep_BW_Ill_1.4_OL_17Oct23.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/neu-refix-%ce%b2-glucano-reduz-a-fibrose-muscular-em-camundongos-mdx-com-distrofia-muscular-de-duchenne-em-pesquisa-conjunta-com-o-dr-yoshitsugu-aoki-do-ncnp-de-toquio-japao\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Neu REFIX \u03b2-glucano reduz a fibrose muscular em camundongos mdx com distrofia muscular de Duchenne em pesquisa conjunta com o dr. Yoshitsugu Aoki do NCNP de T\u00f3quio (Jap\u00e3o)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/#website\",\"url\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/\",\"name\":\"Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios\",\"description\":\"Tudo sobre o mercado empresarial, comunicados e neg\u00f3cios\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/#\\\/schema\\\/person\\\/24f7b50e924d81f1023b69582993c0ff\",\"name\":\"DINO\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ca8348556b3dfd41c825da9ac5643583f369a1092022fb6057420d716f02be0c?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ca8348556b3dfd41c825da9ac5643583f369a1092022fb6057420d716f02be0c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ca8348556b3dfd41c825da9ac5643583f369a1092022fb6057420d716f02be0c?s=96&d=mm&r=g\",\"caption\":\"DINO\"},\"url\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/author\\\/dino\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Neu REFIX \u03b2-glucano reduz a fibrose muscular em camundongos mdx com distrofia muscular de Duchenne em pesquisa conjunta com o dr. Yoshitsugu Aoki do NCNP de T\u00f3quio (Jap\u00e3o) - Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ocanal.com\/noticias\/corporativas\/neu-refix-\u03b2-glucano-reduz-a-fibrose-muscular-em-camundongos-mdx-com-distrofia-muscular-de-duchenne-em-pesquisa-conjunta-com-o-dr-yoshitsugu-aoki-do-ncnp-de-toquio-japao\/","og_locale":"pt_BR","og_type":"article","og_title":"Neu REFIX \u03b2-glucano reduz a fibrose muscular em camundongos mdx com distrofia muscular de Duchenne em pesquisa conjunta com o dr. Yoshitsugu Aoki do NCNP de T\u00f3quio (Jap\u00e3o) - Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios","og_description":"A fibrose no m\u00fasculo esquel\u00e9tico que leva&agrave;disfun\u00e7\u00e3o locomotora na distrofia muscular de Duchenne (DMD) pode ser significativamente reduzida em camundongos mdx com DMD mediante a administra\u00e7\u00e3o por via oral do Neu REFIX beta 1,3-1,6 glucanos em solit\u00e1rio (sem quaisquer outros medicamentos) durante 45 dias. Essa pesquisa foi realizada em conjunto com a equipe do dr. [&hellip;]","og_url":"https:\/\/ocanal.com\/noticias\/corporativas\/neu-refix-\u03b2-glucano-reduz-a-fibrose-muscular-em-camundongos-mdx-com-distrofia-muscular-de-duchenne-em-pesquisa-conjunta-com-o-dr-yoshitsugu-aoki-do-ncnp-de-toquio-japao\/","og_site_name":"Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios","article_published_time":"2023-10-17T16:18:25+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20231016225712\/pt\/1917231\/4\/GNC_PR_65_MDX_Sci_Rep_BW_Ill_1.4_OL_17Oct23.jpg","type":"","width":"","height":""}],"author":"DINO","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"DINO","Est. tempo de leitura":"4 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ocanal.com\/noticias\/corporativas\/neu-refix-%ce%b2-glucano-reduz-a-fibrose-muscular-em-camundongos-mdx-com-distrofia-muscular-de-duchenne-em-pesquisa-conjunta-com-o-dr-yoshitsugu-aoki-do-ncnp-de-toquio-japao\/#article","isPartOf":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/neu-refix-%ce%b2-glucano-reduz-a-fibrose-muscular-em-camundongos-mdx-com-distrofia-muscular-de-duchenne-em-pesquisa-conjunta-com-o-dr-yoshitsugu-aoki-do-ncnp-de-toquio-japao\/"},"author":{"name":"DINO","@id":"https:\/\/ocanal.com\/noticias\/corporativas\/#\/schema\/person\/24f7b50e924d81f1023b69582993c0ff"},"headline":"Neu REFIX \u03b2-glucano reduz a fibrose muscular em camundongos mdx com distrofia muscular de Duchenne em pesquisa conjunta com o dr. Yoshitsugu Aoki do NCNP de T\u00f3quio (Jap\u00e3o)","datePublished":"2023-10-17T16:18:25+00:00","mainEntityOfPage":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/neu-refix-%ce%b2-glucano-reduz-a-fibrose-muscular-em-camundongos-mdx-com-distrofia-muscular-de-duchenne-em-pesquisa-conjunta-com-o-dr-yoshitsugu-aoki-do-ncnp-de-toquio-japao\/"},"wordCount":769,"image":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/neu-refix-%ce%b2-glucano-reduz-a-fibrose-muscular-em-camundongos-mdx-com-distrofia-muscular-de-duchenne-em-pesquisa-conjunta-com-o-dr-yoshitsugu-aoki-do-ncnp-de-toquio-japao\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20231016225712\/pt\/1917231\/4\/GNC_PR_65_MDX_Sci_Rep_BW_Ill_1.4_OL_17Oct23.jpg","articleSection":["Not\u00edcias Corporativas"],"inLanguage":"pt-BR"},{"@type":"WebPage","@id":"https:\/\/ocanal.com\/noticias\/corporativas\/neu-refix-%ce%b2-glucano-reduz-a-fibrose-muscular-em-camundongos-mdx-com-distrofia-muscular-de-duchenne-em-pesquisa-conjunta-com-o-dr-yoshitsugu-aoki-do-ncnp-de-toquio-japao\/","url":"https:\/\/ocanal.com\/noticias\/corporativas\/neu-refix-%ce%b2-glucano-reduz-a-fibrose-muscular-em-camundongos-mdx-com-distrofia-muscular-de-duchenne-em-pesquisa-conjunta-com-o-dr-yoshitsugu-aoki-do-ncnp-de-toquio-japao\/","name":"Neu REFIX \u03b2-glucano reduz a fibrose muscular em camundongos mdx com distrofia muscular de Duchenne em pesquisa conjunta com o dr. Yoshitsugu Aoki do NCNP de T\u00f3quio (Jap\u00e3o) - Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios","isPartOf":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/neu-refix-%ce%b2-glucano-reduz-a-fibrose-muscular-em-camundongos-mdx-com-distrofia-muscular-de-duchenne-em-pesquisa-conjunta-com-o-dr-yoshitsugu-aoki-do-ncnp-de-toquio-japao\/#primaryimage"},"image":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/neu-refix-%ce%b2-glucano-reduz-a-fibrose-muscular-em-camundongos-mdx-com-distrofia-muscular-de-duchenne-em-pesquisa-conjunta-com-o-dr-yoshitsugu-aoki-do-ncnp-de-toquio-japao\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20231016225712\/pt\/1917231\/4\/GNC_PR_65_MDX_Sci_Rep_BW_Ill_1.4_OL_17Oct23.jpg","datePublished":"2023-10-17T16:18:25+00:00","author":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/#\/schema\/person\/24f7b50e924d81f1023b69582993c0ff"},"breadcrumb":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/neu-refix-%ce%b2-glucano-reduz-a-fibrose-muscular-em-camundongos-mdx-com-distrofia-muscular-de-duchenne-em-pesquisa-conjunta-com-o-dr-yoshitsugu-aoki-do-ncnp-de-toquio-japao\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ocanal.com\/noticias\/corporativas\/neu-refix-%ce%b2-glucano-reduz-a-fibrose-muscular-em-camundongos-mdx-com-distrofia-muscular-de-duchenne-em-pesquisa-conjunta-com-o-dr-yoshitsugu-aoki-do-ncnp-de-toquio-japao\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/ocanal.com\/noticias\/corporativas\/neu-refix-%ce%b2-glucano-reduz-a-fibrose-muscular-em-camundongos-mdx-com-distrofia-muscular-de-duchenne-em-pesquisa-conjunta-com-o-dr-yoshitsugu-aoki-do-ncnp-de-toquio-japao\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20231016225712\/pt\/1917231\/4\/GNC_PR_65_MDX_Sci_Rep_BW_Ill_1.4_OL_17Oct23.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20231016225712\/pt\/1917231\/4\/GNC_PR_65_MDX_Sci_Rep_BW_Ill_1.4_OL_17Oct23.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/ocanal.com\/noticias\/corporativas\/neu-refix-%ce%b2-glucano-reduz-a-fibrose-muscular-em-camundongos-mdx-com-distrofia-muscular-de-duchenne-em-pesquisa-conjunta-com-o-dr-yoshitsugu-aoki-do-ncnp-de-toquio-japao\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/ocanal.com\/noticias\/corporativas\/"},{"@type":"ListItem","position":2,"name":"Neu REFIX \u03b2-glucano reduz a fibrose muscular em camundongos mdx com distrofia muscular de Duchenne em pesquisa conjunta com o dr. Yoshitsugu Aoki do NCNP de T\u00f3quio (Jap\u00e3o)"}]},{"@type":"WebSite","@id":"https:\/\/ocanal.com\/noticias\/corporativas\/#website","url":"https:\/\/ocanal.com\/noticias\/corporativas\/","name":"Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios","description":"Tudo sobre o mercado empresarial, comunicados e neg\u00f3cios","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ocanal.com\/noticias\/corporativas\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Person","@id":"https:\/\/ocanal.com\/noticias\/corporativas\/#\/schema\/person\/24f7b50e924d81f1023b69582993c0ff","name":"DINO","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/secure.gravatar.com\/avatar\/ca8348556b3dfd41c825da9ac5643583f369a1092022fb6057420d716f02be0c?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/ca8348556b3dfd41c825da9ac5643583f369a1092022fb6057420d716f02be0c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ca8348556b3dfd41c825da9ac5643583f369a1092022fb6057420d716f02be0c?s=96&d=mm&r=g","caption":"DINO"},"url":"https:\/\/ocanal.com\/noticias\/corporativas\/author\/dino\/"}]}},"_links":{"self":[{"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/posts\/10849","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/comments?post=10849"}],"version-history":[{"count":0,"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/posts\/10849\/revisions"}],"wp:attachment":[{"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/media?parent=10849"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/categories?post=10849"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/tags?post=10849"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}